CoChat

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To compare the effects of two antihypertensive treatment strategies for the prevention of coronary heart disease and other cardiovascular events in the large subpopulation (n=5137) with diabetes mellitus in the blood pressure-lowering arm of the Anglo-Scandinavian Cardiac Outcomes Trial. METHODS: Patients had either untreated hypertension or treated hypertension. For those with type II diabetes mellitus, inclusion criteria required at least two additional risk factors. Patients were randomized to amlodipine with addition of perindopril as required (amlodipine-based) or atenolol with addition of thiazide as required (atenolol-based). Therapy was titrated to achieve a target blood pressure of less than 130/80 mmHg. RESULTS: The trial was terminated early due to significant benefits on mortality and stroke associated with the amlodipine-based regimen. In patients with diabetes mellitus, the amlodipine-based treatment reduced the incidence of the composite endpoint--total cardiovascular events and procedures--compared with the atenolol-based regimen (hazard ratio 0.86, confidence interval 0.76-0.98, P=0.026). Fatal and nonfatal strokes were reduced by 25% (P=0.017), peripheral arterial disease by 48% (P=0.004) and noncoronary revascularization procedures by 57% (P<0.001). For the other endpoints included in the composite, the endpoint differences were less clear including coronary heart disease deaths and nonfatal myocardial infarctions (the primary endpoint), which were reduced nonsignificantly by 8% (hazard ratio 0.92, confidence interval 0.74-1.15). CONCLUSION: In the large diabetic subgroup in the blood pressure-lowering arm of the Anglo-Scandinavian Cardiac Outcomes Trial, the benefits of amlodipine-based treatment, compared with atenolol-based treatment, on the incidence of total cardiovascular events and procedures was significant (14% reduction) and similar to that observed in the total trial population (16% reduction).

Overview

Integrity signals

Registry

Crossref · 10.1097/hjh.0b013e328310e0d9

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 1

  1. Lievre, 2000, INDANA Steering Committee. Efficacy of diuretics and β-blockers in diabetic hypertensive patients: results from a meta-analysis, Diabetes Care, 23, B65

Cited by

See all 116

Metadata

Authors
Östergren, J., Poulter, N. R., Sever, P. S., Dahlöf, B., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., Mehlsen, J., Nieminen, M., & O'Brien, E.
Affiliations
  • Karolinska University Hospital (SE)
  • Imperial College London (GB)
  • Sahlgrenska University Hospital (SE)
  • Nordic School of Public Health (SE)
  • Birmingham City Hospital (GB)
  • Queen Mary University of London (GB)
  • University of Oxford (GB)
  • Oslo University Hospital (NO)
  • National University Hospital of Iceland (IS)
  • University of Glasgow (GB)
  • Frederiksberg Hospital (DK)
  • Helsinki University Hospital (FI)
  • Beaumont Hospital (IE)
Corresponding author
Östergren, Jan
Venue
Journal of Hypertension
Published
2008-11
Volume
26
Issue
11
Pages
2103-2111
ISSN
0263-6352 (ISSN-L)
OpenAlex
W2106630546
Cited by
116
References
31
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 7 · 2017: 6 · 2016: 3 · 2015: 4 · 2014: 18 · 2013: 11 · 2012: 7
FWCI
8.48
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Pfizer
  • Heart and Stroke Foundation of Canada
  • Servier
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Keywords
type 2 diabetes, hypertension, amlodipine, atenolol, perindopril, thiazide diuretics, combination antihypertensive therapy, cardiovascular events, stroke, peripheral arterial disease, coronary artery disease
MeSH terms
Adult, Aged, Antihypertensive Agents, Atenolol, Blood Pressure, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Female, United Kingdom, Humans, Hypertension, Male, Middle Aged, Scandinavian and Nordic Countries, Peripheral Vascular Diseases, Amlodipine, Stroke, Perindopril, Thiazides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes. https://app.cochat.ai/papers/10.1097/hjh.0b013e328310e0d9
The paper
Östergren, J., Poulter, N. R., Sever, P. S., Dahlöf, B., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., Mehlsen, J., Nieminen, M., & O'Brien, E. (2008). The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e328310e0d9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.